Skip to main content
Fig. 11 | Journal of Nanobiotechnology

Fig. 11

From: Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches

Fig. 11

Comparison between the studied groups [free RSV/PMT co-solvent Mann-targeted RSV/PMT BSA-QDs NPs (F3) and non-targeted RSV/PMT-BSA-QDs NPs (F2)-mice treated groups] in addition to the positive control group according to active caspase-3 and VEGF-1 levels (a). *p < 0.05 vs. positive control, #p < 0.05 vs. free RSV + PMT, Πp < 0.05 vs. F2 (non-targeted NPs). Assessment of immunogenicity of the BSA nano-delivery systems (b). No significant difference was found in immunogenic response between the treated groups and the control group (p > 0.05 by ANOVA test and Tukey–Kramer post hoc multiple comparison test)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us